Radiation Oncology

Targeted therapies

Questions discussed in this category

In stage II/III node positive patients with driver mutations positive NSCLC who are not surgical candidates and are unlikely to tolerate concurrent chemotherapy and radiation, would you consider radiation alone, TKI alone, or would you ever consider TKI + RT?

What would be the treatment duration if using oral TKI?

1 Answer available

Related Topics in Radiation Oncology